You are here: Home » News-IANS » Business-Economy
Business Standard

FHL receives new offer from Manipal-TPG, share price hiked to Rs 180

IANS  |  Mumbai 

Healthcare (FHL) on Monday said that it has received a "modified" new offer from the consortium of Health Enterprises (MHEPL) and private equity (PE) firm

As per a BSE filing, said that its Board has received a "modified" new offer from and with a proposal which values the company at Rs 9,403 crore at a share price of Rs 180 per share.

"We have been following the developments of the past few days after the announcement by and have observed, through media reports, the negative reaction of the shareholders to the decisions of the to accept the offer," Health Enterprises said in its offer letter.

"The modified new offer is not only financially beneficial for FHL and its stakeholders in the short term but also solves the larger issues facing FHL, including FHL's payment obligation for the acquisition of the relevant Indian entities from RHT and the exit required to be provided by FHL to the private equity investors in SRL."

On May 6, the consortium of MHEPL and revised their offer to acquire a stake in FHL, proposing to infuse Rs 2,100 crore into the company at a share price of Rs 160 per share. That time the consortium had proposed to merge MHEPL into FHL with the latter valued at Rs 8,358 crore.

The development comes days after the on May 10 decided to recommend the offer of the family consortium for sale of its business to the shareholders for their approval later this month.

on May 11 had said: "The Board, by a majority, decided to recommend the Hero-Burman family offer to shareholders looking at the binding bids for the point of certainty of liquidity flowing into the company."

The company said that the entire exercise for selecting the consortium involved a process that witnessed "deliberation and recommendation" by an independent (EAC).

The EAC comprised Deepak Kapoor, former of (India), and Lalit Bhasin, of the Indian Society of Law Firms, along with two -- and -- while were the

The deal envisages an upfront equity infusion of Rs 800 crore at a price of Rs 167 per share through preferential allotment. The Munjal-Burman consortium has also offered a further amount of Rs 1,000 crore through preferential issue of warrants.

"There will be a shareholders' EGM on this on May 22 and I am positive that there will be support from the shareholders for the decision," he said on May 11.

Fortis' board had received offers from suitors such as Hero Enterprise Investment Office, Burman Family Office, Fosun Health Holdings, Malaysia's IHH Healthcare Berhad, and Radiant Life Care for infusion of funds. The bid winners' offer was not the highest.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, May 14 2018. 21:54 IST